Cannabics Pharmaceuticals Inc. Appoints Dr. Inbar Maymon Pomeranchik as Independent Board Member
July 06, 2021 at 12:24 pm
Cannabics Pharmaceuticals Inc. announced that on July 1, 2021, the Board of Directors appointed Dr. Inbar Maymon Pomeranchik as an Independent Board Member. Dr. Maymon-Pomeranchik, is trained as a PhD in molecular and genetic research and brings nearly 20 years of Executive level experience in biotech sciences, with particular expertise in the global medical cannabis industry.